Zealand Pharma Logo

Zealand Pharma

Developing innovative peptide medicines for metabolic and inflammatory diseases.

ZEAL | CO

Overview

Corporate Details

ISIN(s):
DK0060257814 (+2 more)
LEI:
549300ITBB1ULBL4CZ12
Country:
Denmark
Address:
Sydmarken 11, 2860 Søborg
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Zealand Pharma is a biotechnology company specializing in the discovery, design, and development of innovative peptide-based medicines. With over 25 years of expertise in peptide engineering, the company focuses on creating next-generation therapeutics for metabolic and inflammatory diseases. Its clinical pipeline targets conditions with significant unmet medical needs, including obesity, congenital hyperinsulinism, short bowel syndrome, and chronic autoimmune diseases. Key programs involve novel peptide analogs such as amylin, long-acting GLP-2, and dual agonists for GLP-1/GLP-2 and glucagon/GLP-1 receptors. The company advances its portfolio through both proprietary development and strategic partnerships with major pharmaceutical firms.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-17 17:05
Major Shareholding Notification
English 5.6 KB
2025-10-17 17:05
Major Shareholding Notification
English 553.9 KB
2025-10-17 17:05
Major Shareholding Notification
English 377.4 KB
2025-09-30 17:05
Declaration of Voting Results & Voting Rights Announcements
English 5.6 KB
2025-09-11 22:00
Share Issue/Capital Change
English 5.9 KB
2025-08-20 22:00
Major Shareholding Notification
English 5.6 KB
2025-08-20 22:00
Major Shareholding Notification
English 550.7 KB
2025-08-20 22:00
Major Shareholding Notification
English 367.5 KB
2025-08-14 07:00
Earnings Release
English 25.7 KB
2025-08-14 07:00
Earnings Release
English 891.1 KB
2025-07-18 18:30
Major Shareholding Notification
English 301.0 KB
2025-07-18 18:30
Major Shareholding Notification
English 5.6 KB
2025-07-18 18:30
Major Shareholding Notification
English 516.4 KB
2025-06-30 17:05
Declaration of Voting Results & Voting Rights Announcements
English 5.6 KB
2025-06-18 17:29
Regulatory News Service
English 14.1 KB

Automate Your Workflow. Get a real-time feed of all Zealand Pharma filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Zealand Pharma

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Zealand Pharma via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Fine Foods & Pharmaceuticals Ntm Logo
Contract development & manufacturing of oral solids for pharma, nutraceutical & cosmetic sectors.
Italy FF
Formycon AG Logo
Develops cost-effective biosimilars for ophthalmology, immunology, and other chronic diseases.
Germany FYB
Friulchem Logo
CDMO for animal health, providing vet pharma & supplement solutions for pets and livestock.
Italy FCM
Fuji Pharma Co.,Ltd. Logo
Specializes in hormone medicines for ob/gyn, injectables, and contract manufacturing.
Japan 4554
Fuso Pharmaceutical Industries,Ltd. Logo
Manufactures essential pharmaceuticals like dialysis drugs, infusions, and injections for healthcare.
Japan 4538
FutureChem Co., Ltd. Logo
Develops radiopharmaceuticals & diagnostic agents for cancer, Alzheimer's, and Parkinson's disease.
South Korea 220100
Future Medicine  Co., Ltd. Logo
Clinical-stage biopharma developing novel synthetic drugs for inflammation, fibrosis, and oncology.
South Korea 341170
Develops long-acting injectable therapies for chronic diseases and cancer.
South Korea 456160
Gabather AB Logo
Developing novel GABAA receptor drugs for neuropsychiatric disorders.
Sweden GABA
Galapagos NV Logo
Biotech firm developing novel CAR-T cell therapies for oncology via a rapid delivery platform.
Belgium GLPG

Talk to a Data Expert

Have a question? We'll get back to you promptly.